Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention

Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would reduce bleeding complications without compromising the rate of ischemic events compared to heparin plus GP IIb/IIIa inh...

Descripción completa

Detalles Bibliográficos
Autor principal: Centurión, Osmar Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002443/
https://www.ncbi.nlm.nih.gov/pubmed/27583038
http://dx.doi.org/10.2174/1874192401610010122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002443/
https://www.ncbi.nlm.nih.gov/pubmed/27583038
http://dx.doi.org/10.2174/1874192401610010122

Ejemplares similares